Dr. Mayo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Road
L619
Portland, OR 97202Phone+1 503-494-5501
Summary
- Dr. Skye Mayo is a general surgeon in Portland, OR. He received his medical degree from Oregon Health & Science University School of Medicine and has been in practice 11 years. He specializes in hepatobiliary surgery, pancreas, and surgical oncology (other than breast) and is experienced in cholangiocarcinoma, retroperitoneal sarcoma, neuroendocrine tumors, surgical oncology (non-breast), and pancreatic surgery.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2013 - 2015
- Johns Hopkins UniversityResidency, Surgery, 2006 - 2013
- Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2009 - 2011
- Oregon Health and Science UniversityMPH, Epidemiology and Biostatistics, 2001 - 2006
- Oregon Health and Science University School of MedicineClass of 2006
- Stanford UniversityBS, Biological Sciences, Honors in Human Biology, 1996 - 2000
Certifications & Licensure
- ID State Medical License 2021 - 2026
- OR State Medical License 2015 - 2025
- NY State Medical License 2013 - 2016
- MD State Medical License 2009 - 2011
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer.Ranish K Patel, Michael Parappilly, Hannah C Farley, Emile J Latour, Lei G Wang
Cancers. 2024-10-29 - ASO Author Reflections: Is It Time to Re-evaluate Floxuridine Dosing for Hepatic Arterial Infusion?Issac R Schwantes, Ranish K Patel, Adel Kardosh, Charles D Lopez, Skye C Mayo
Annals of Surgical Oncology. 2024-10-01 - A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion.Issac R Schwantes, Ranish K Patel, Adel Kardosh, Jillian Paxton, Robert Eil
Annals of Surgical Oncology. 2024-10-01
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- Connective Tissue Oncology Society (CTOS)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: